Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?: Commentary

Andre De Wolf; Michael Abecassis

doi:10.1038/ncpgasthep0869

Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events? Commentary

Andre De Wolf, Michael Abecassis^*

^*Corresponding author for this work

Surgery, Transplant Surgery Division

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	422-423
Number of pages	2
Journal	Nature Clinical Practice Gastroenterology and Hepatology
Volume	4
Issue number	8
DOIs	https://doi.org/10.1038/ncpgasthep0869
State	Published - Aug 2007

ASJC Scopus subject areas

Gastroenterology
Hepatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/ncpgasthep0869

Cite this

@article{fc1899f50b1c4b86bbe0046341047a8f,

title = "Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?: Commentary",

author = "{De Wolf}, Andre and Michael Abecassis",

year = "2007",

month = aug,

doi = "10.1038/ncpgasthep0869",

language = "English (US)",

volume = "4",

pages = "422--423",

journal = "Nature Clinical Practice Gastroenterology and Hepatology",

issn = "1743-4378",

publisher = "Nature Research",

number = "8",

}

TY - JOUR

T1 - Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?

T2 - Commentary

AU - De Wolf, Andre

AU - Abecassis, Michael

PY - 2007/8

Y1 - 2007/8

UR - http://www.scopus.com/inward/record.url?scp=34547686040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547686040&partnerID=8YFLogxK

U2 - 10.1038/ncpgasthep0869

DO - 10.1038/ncpgasthep0869

M3 - Short survey

C2 - 17579588

AN - SCOPUS:34547686040

SN - 1743-4378

VL - 4

SP - 422

EP - 423

JO - Nature Clinical Practice Gastroenterology and Hepatology

JF - Nature Clinical Practice Gastroenterology and Hepatology

IS - 8

ER -

Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events? Commentary

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this